Status:
UNKNOWN
Use of Vitamin D as An Adjuvant Treatment in Children With Chronic Idiopathic Thrombocytopenic Purpura
Lead Sponsor:
Mansoura University
Conditions:
Immune Thrombocytopenia
Eligibility:
All Genders
1-18 years
Phase:
EARLY_PHASE1
Brief Summary
Immune thrombocytopenia is an autoimmune disease in which platelets are targeted by the host immune system. Platelet depletion occurs when autoantibodies targeting glycoproteins (αIIb-β3 and GPIb) fou...
Detailed Description
Introduction Immune thrombocytopenia is an autoimmune disease in which platelets are targeted by the host immune system. Platelet depletion occurs when autoantibodies targeting glycoproteins (αIIb-β3...
Eligibility Criteria
Inclusion
- Chirdren from 1 year to 18 years.
- Diagnosed with Chronic ITP .
- Platelet count \<100,000/microL.
Exclusion
- Other causes of thrombocytopenia.
- Acute and persistant ITP.
- Dysmorphic feature.
- Patients with other comorbidities.
Key Trial Info
Start Date :
December 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06073925
Start Date
December 1 2023
End Date
October 1 2024
Last Update
October 10 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.